Shah Sandeep N, Eckert Kristin A
Department of Pathology, Gittlen Cancer Research Foundation and Intercollege Graduate Degree Program in Genetics, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.
Cancer Res. 2009 Feb 1;69(3):1143-9. doi: 10.1158/0008-5472.CAN-08-3499. Epub 2009 Jan 20.
The mismatch repair (MMR) system plays a major role in removing DNA polymerization errors, and loss of this pathway results in hereditary cancers characterized by microsatellite instability. We investigated microsatellite stability during DNA replication within human postmeiotic segregation 2 (hPMS2)-deficient and proficient human lymphoblastoid cell lines. Using a shuttle vector assay, we measured mutation rates at reporter cassettes containing defined mononucleotide, dinucleotide, and tetranucleotide microsatellite sequences. A mutator phenotype was observed in the hPMS2-deficient cell line. The mutation rate of vectors containing G/C or GT/CA alleles was elevated 20-fold to 40-fold in hPMS2-deficient cells, relative to an hPMS2-expressing cell line. We observed a 6-fold and 12-fold relative increase in mutation rate of TTTC/AAAG and TTCC/AAGG sequences, respectively, in hPMS2-deficient cells. Mutational specificity analyses suggested that repair by hPMS2 is biased. In the absence of hPMS2, a greater number of microsatellite expansion versus deletion mutations was observed, and expansion rates of the tetranucleotide alleles were similar. In the presence of hPMS2, we observed a 29-fold decrease in the TTCC/AAGG expansion rate but only a 6-fold decrease for the TTTC/AAAG allele. Our data indicate that hPMS2 is more protective of tetranucleotide expansions than deletions and that hPMS2 displays a sequence bias, wherein [TTCC/AAGG] sequences are stabilized to a greater extent than [TTTC/AAAG]. Our results allow for greater accuracy during identification of MMR defects by providing a mutational signature characteristic of hPMS2 defect. This study also provides clues to possible mechanisms of repair by hPMS2 in the context of the MMR system.
错配修复(MMR)系统在消除DNA聚合错误方面发挥着主要作用,该通路的缺失会导致以微卫星不稳定为特征的遗传性癌症。我们研究了人类减数分裂后分离2(hPMS2)缺陷型和正常型人类淋巴母细胞系在DNA复制过程中的微卫星稳定性。使用穿梭载体测定法,我们测量了含有特定单核苷酸、二核苷酸和四核苷酸微卫星序列的报告盒的突变率。在hPMS2缺陷型细胞系中观察到了突变体表型。相对于表达hPMS2的细胞系,在hPMS2缺陷型细胞中,含有G/C或GT/CA等位基因的载体的突变率提高了20倍至40倍。我们观察到,在hPMS2缺陷型细胞中,TTTC/AAAG和TTCC/AAGG序列的突变率分别相对增加了6倍和12倍。突变特异性分析表明,hPMS2介导的修复存在偏向性。在缺乏hPMS2的情况下,观察到微卫星扩增突变比缺失突变更多,并且四核苷酸等位基因的扩增率相似。在有hPMS2的情况下,我们观察到TTCC/AAGG的扩增率下降了29倍,但TTTC/AAAG等位基因仅下降了6倍。我们的数据表明,hPMS2对四核苷酸扩增的保护作用比对缺失的保护作用更强,并且hPMS2表现出序列偏向性,其中[TTCC/AAGG]序列比[TTTC/AAAG]序列更稳定。我们的结果通过提供hPMS2缺陷的突变特征,提高了在识别MMR缺陷过程中的准确性。这项研究还为hPMS2在MMR系统背景下的可能修复机制提供了线索。